QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.
External link for QIAGEN
🧬 Happy DNA Day! Did you know that when DNA was first discovered, it wasn't called DNA at all? In 1869, Friedrich Miescher isolated a mysterious phosphorous-rich acidic substance from the nuclei of white blood cells during his experiments at the University of Tuebingen. This substance, reflecting its origin and properties, was given a particular name by Miescher.
This content isn’t available here
Access this content and more in the LinkedIn app
✨ As we commemorate World Laboratory Day, we reflect on our commitment to sustainability within our laboratory practices. Learn more 👉 https://lnkd.in/ePwJmQ_3 🙌 Understanding the importance of reducing plastic usage, we take pride in the accomplishments of our Sample Technologies lab, which recently achieved QIAGEN’s first Platinum My Green Lab certification. ✅ Our QIAwave Kits highlight our dedication, offering a reduction in plastic use by up to 63% per kit as compared to QIAGEN’s standard kits. With updated ACT labels, molecular biologists using QIAGEN kits now have the option to reduce plastic consumption in their daily work. Join us in embracing sustainability in the laboratory. #worldlaboratoryday #sustainabilityinthelab #sustainability
🌏 When it comes to driving environmental responsibility at QIAGEN, Rosa Garduno is one of the pivotal figures. Rosa, who joined us in 2013 and works in the finance department, extends her role beyond financial reporting; she is a passionate advocate for safeguarding the environment. As an active member of QIAGreen Mexico – a team comprised of volunteers who exemplify the impact that Employee Resource Groups can have – she supports initiatives to reduce the ecological footprint and promote environmental stewardship. “Caring for natural resources is fundamental to our survival,” Rosa emphasizes.”'It's up to us to ensure future generations inherit a thriving planet.” Since 2018, Rosa has spearheaded efforts to make QIAGEN a greener company, from reducing paper usage to implementing innovative programs like the Barter Market initiative, which helps people give a second life to items they no longer use. Rosa encourages individual action in creating a sustainable future and invites us all to take the first step today. #Sustainability #Sustainable #EarthDay
Misdiagnosis of #TB can cost lives - unnecessarily. Traditional skin tests lead to misdiagnoses in about 50% of TB cases. Dr. Wendy Thanassi advocates for expanding TB testing beyond #healthcare into other high-risk professions using QuantiFERON - an innovative blood test with higher accuracy - to prevent these tragedies. Read her story on how she plans to eliminate TB 👉 https://lnkd.in/ex2_GefS
💡 Hands-on learning for aspiring scientists! Recently, we hosted 10 international PhD students at our Hilden site, who got the unique chance to dive into a Liquid Biopsy workflow and explore our technologies. 🎓 These bright minds from 7 different countries across 4 continents learned about isolating meaningful bioanalytes and experienced the potential impact of their research on diseases like cancer. Not only did they get to practice using our latest instruments, but they also engaged with QIAGEN professionals from various departments who shared valuable insights about pursuing careers in the industry. 🔍 We loved giving these students a behind-the-scenes look at our production facilities and showcasing the diverse opportunities that we offer. It’s all about empowering the next generation of scientists!
✅ Doctors can’t treat what they can’t see – that's why diagnostics matter. We want to help you transform medicine with molecular tech. Come chat with us at ECCMID booth D20 to learn how we can work together. Explore our full ECCMID program now. 👉 https://lnkd.in/e4hC37cw #ECCMID #ECCMID2024
Sensitive technologies like digital PCR & liquid biopsy are elevating companion diagnostics, making cancer therapies more personalized than ever. These next-generation tests help more precisely tailor cancer therapy, offering patients a more powerful approach to overcoming their diagnosis and reclaiming their health. Meet Marzia Del Re, assistant professor in the Department of Clinical and Experimental Medicine at the Università di Pisa, who is working towards making precision medicine even more precise. Read more 👉 https://lnkd.in/eaDe3TFw
What type of regulation do diagnostic tests need? Our CEO Thierry BERNARD and Scott Whitaker, CEO of AdvaMed, argue that the proposed VALID Act meets the dynamic needs of existing and emerging technology without compromising quality or patient safety. Read more 👉 https://lnkd.in/eBVRmUis
Driven by our commitment to providing answers for victims and preventing further crimes, we are thrilled to launch our sensitive solution for the screening of sexual assault forensic casework samples. Learn more 👉 https://lnkd.in/eVVYwv_M ✅ Our Investigator Quantiplex Pro FLX Kit boosts workflow efficiency and throughput, maximizes sensitivity thanks to lyophilized reagents and flexible input volumes. ✅ This kit includes breakable plates and convenient seal removal, which are suitable for any throughput needs, while room temperature storage frees up freezer capacity. ✅ The Investigator Quantiplex Pro FLX Kit enhances the processing of casework samples, facilitating downstream workflow decisions, reducing backlogs, and bringing answers to victims faster.
🤩 Exciting news! We're strengthening our portfolio for cancer research, showcasing our latest product launches at the AACR Annual Meeting 2024. Learn more 👉 https://lnkd.in/e-aajjnG ✅ Our new QIAcuity dPCR PanCancer Kits enable researchers to simultaneously detect rare mutations in the EGFR and BRAF genes, while saving sample material and reducing both time and costs. ✅ To advance research on the interaction between the immune system and cancer, we have introduced the QIAseq Targeted RNA-seq Panel for T-cell Receptor that enables targeted next-generation sequencing of T-cell receptors, enhancing accuracy and sensitivity. ✅ The PAXgene Urine Liquid Biopsy Set, which will be launched later this year, enables non-invasive sample collection and cell-free DNA stabilization, thereby allowing researchers to make advances in urine liquid biopsy. 📅 These three new products, along with the IVD version of QIAcuity, which will be available in mid-2024, are to be featured at the AACR Annual Meeting 2024 from April 5-10. #Cancerresearch #AACR #AACR2024
QGEN
NYSE
20 minutes delay
$40.69
-0.83 (-1.999%)
Data from Refinitiv
See more info on